Open access
74
Views
0
CrossRef citations to date
0
Altmetric
Original Research
The Impact of Exacerbation History on the Safety and Efficacy of Aclidinium in Patients with Chronic Obstructive Pulmonary Disease and Increased Cardiovascular Risk: ASCENT-COPD Trial
Robert A Wise1 Medicine, Pulmonary and Critical Care, Johns Hopkins University School of Medicine, Baltimore, MD, USACorrespondence[email protected]
https://orcid.org/0000-0002-8353-2349View further author information
Kenneth R Chapman2 Department of Medicine, University of Toronto, Toronto, ON, Canada
https://orcid.org/0000-0002-2498-9859View further author information
Benjamin M Scirica3 Cardiovascular Division, Brigham and Women’s Hospital, Boston, MA, USA;4 Department of Medicine, Harvard Medical School, Boston, MA, USAView further author information
, Sami Z Daoud5 Late-Stage Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
, Dan Lythgoe6 Statistics, Phastar, Chiswick, London, UK
https://orcid.org/0000-0002-4682-772XView further author information
Esther Garcia-Gil7 Respiratory & Immunology, BioPharmaceuticals Medical, AstraZeneca, Barcelona, SpainView further author information
Pages 689-699
|
Published online: 18 Mar 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.